Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hangeshashinto for refractory overactive bladder
jRCTs071200035Completed
- Start
- Aug 2020
- Countries
- 1
01
Overview
Open-label, single-arm trial of Banxia Xiexin Decoction in overactive bladder (OAB). Primary endpoint: OABSS total score. Started Aug 2020; status: completed.
02
Drugs
Banxia Xiexin Decoction
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on jRCTs071200035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071200035.